UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humans

The Journal of pharmacology and experimental therapeutics, 2003-11, Vol.307 (2), p.476-480

2003

Volltextzugriff (PDF)

Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma

Anti-cancer drugs, 2008-06, Vol.19 (5), p.547-552

2008

Volltextzugriff (PDF)

Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2355-2364

1999

Volltextzugriff (PDF)

Early identification of therapeutic failure in nonseminomatous germ cell tumors by assessing serum tumor marker decline during chemotherapy: still not ready for routine clinical use

Journal of clinical oncology, 2004-10, Vol.22 (19), p.3842-3845

Toner, Guy C

2004

Volltextzugriff (PDF)

Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel

Gynecologic oncology, 1996-10, Vol.63 (1), p.89-93

1996

Volltextzugriff (PDF)

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial

The Lancet (British edition), 2001-03, Vol.357 (9258), p.739-745

2001

Volltextzugriff (PDF)

Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor

Oncogene, 2004-02, Vol.23 (8), p.1618-1626

2004

Volltextzugriff (PDF)

Improved haematopoietic recovery following transplantation with ex vivo‐expanded mobilized blood cells

British journal of haematology, 2004-08, Vol.126 (4), p.536-545

2004

Volltextzugriff (PDF)

A randomised crossover trial of chemotherapy in the home : patient preferences and cost analysis

Medical journal of Australia, 2000-08, Vol.173 (3), p.125-127

2000

Volltextzugriff (PDF)

Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer

Journal of clinical oncology, 1997-02, Vol.15 (2), p.750-758

1997

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics

Annals of oncology, 2002-11, Vol.13 (11), p.1810-1818

2002

Volltextzugriff (PDF)

Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer

Journal of clinical oncology, 1996-01, Vol.14 (1), p.142-148

1996

Volltextzugriff (PDF)

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection

Journal of clinical oncology, 1990-10, Vol.8 (10), p.1683-1694

1990

Volltextzugriff (PDF)

Residual Masses After Chemotherapy for Metastatic Testicular Cancer: The Clinical Implications of the Association between Retroperitoneal and Pulmonary Histology

The Journal of urology, 1997-08, Vol.158 (2), p.474-478

1997

Volltextzugriff (PDF)

Serum tumor marker half-life-during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors

Cancer research (Chicago, Ill.), 1990-09, Vol.50 (18), p.5904-5910

1990

Volltextzugriff (PDF)

Phase I trial of cremophor EL with bolus doxorubicin

Clinical cancer research, 1998-10, Vol.4 (10), p.2321-2329

1998

Volltextzugriff (PDF)

Cremophor Pharmacokinetics in Patients Receiving 3-, 6-, and 24-Hour Infusions of Paclitaxel

JNCI : Journal of the National Cancer Institute, 1996-09, Vol.88 (18), p.1297-1301

1996

Volltextzugriff (PDF)

Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor : Prediction of histology

Cancer, 1997-01, Vol.79 (2), p.345-355

1997

Volltextzugriff (PDF)

Poor prognosis germ cell tumors: current status and future directions

Seminars in oncology, 1998-04, Vol.25 (2), p.194-202

1998

Volltextzugriff (PDF)

Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison

Journal of clinical oncology, 1998-12, Vol.16 (12), p.3874-3879

1998

Volltextzugriff (PDF)

Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors

Annals of oncology, 1999-08, Vol.10 (8), p.907-914

1999

Volltextzugriff (PDF)

Chronic Hiccups Following Chemotherapy

Journal of pain and symptom management, 1999-12, Vol.18 (6), p.387-388

1999

Volltextzugriff (PDF)

The management of testicular cancer in Victoria, 1988–1993

Medical journal of Australia, 2001-04, Vol.174 (7), p.328-331

2001

Volltextzugriff (PDF)

Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features

Cancer, 1991-04, Vol.67 (8), p.2049-2057

1991

Volltextzugriff (PDF)

Docetaxel effectively mobilizes peripheral blood CD34+ cells

Bone marrow transplantation (Basingstoke), 2000-09, Vol.26 (5), p.483-487

2000

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(53)
Humans
(49)
Middle Aged
(36)
Biological And Medical Sciences
(34)
Female
(33)
Medical Sciences
(33)
Adult
(31)
Oncology
(28)
Male
(26)
Aged
(23)
Pharmacology. Drug Treatments
(23)
Antineoplastic Agents
(21)
Chemotherapy
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Paclitaxel - Administration & Dosage
(12)
General & Internal Medicine
(11)
Medicine, General & Internal
(11)
Combined Modality Therapy
(10)
Hematology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humans

Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma

Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer

Early identification of therapeutic failure in nonseminomatous germ cell tumors by assessing serum tumor marker decline during chemotherapy: still not ready for routine clinical use

Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial

Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor

Improved haematopoietic recovery following transplantation with ex vivo‐expanded mobilized blood cells

A randomised crossover trial of chemotherapy in the home : patient preferences and cost analysis

Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics

Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection

Residual Masses After Chemotherapy for Metastatic Testicular Cancer: The Clinical Implications of the Association between Retroperitoneal and Pulmonary Histology

Serum tumor marker half-life-during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors

Phase I trial of cremophor EL with bolus doxorubicin

Cremophor Pharmacokinetics in Patients Receiving 3-, 6-, and 24-Hour Infusions of Paclitaxel

Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor : Prediction of histology

Poor prognosis germ cell tumors: current status and future directions

Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison

Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors

Chronic Hiccups Following Chemotherapy

The management of testicular cancer in Victoria, 1988–1993

Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features

Docetaxel effectively mobilizes peripheral blood CD34+ cells

Suchergebnisse filtern